Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;49(2):137-142.
doi: 10.1016/j.ajic.2020.11.018. Epub 2020 Nov 20.

Willingness to get the COVID-19 vaccine with and without emergency use authorization

Jeanine P D Guidry  1 , Linnea I Laestadius  2 , Emily K Vraga  3 , Carrie A Miller  4 , Paul B Perrin  5 , Candace W Burton  6 , Mark Ryan  4 , Bernard F Fuemmeler  4 , Kellie E Carlyle  4
Affiliations

Willingness to get the COVID-19 vaccine with and without emergency use authorization

Jeanine P D Guidry et al. Am J Infect Control. 2021 Feb.

Abstract

Background: This study assessed psychosocial predictors of U.S. adults' willingness to get a future COVID-19 vaccine and whether these predictors differ under an emergency use authorization (EUA) release of the vaccine.

Methods: A survey of 788 U.S. adults was conducted to explore the relationships between demographics and psychosocial predictors of intent to get a future COVID-19 vaccine as well as willingness to get such a vaccine under EUA.

Results: Significant predictors of COVID-19 vaccine uptake intentions were education, having insurance, scoring high on subjective norms, a positive attitude toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, scoring low on barriers to the vaccine, and scoring high on self-efficacy. Predictors of willingness to take a COVID-19 vaccine under EUA were age, race/ethnicity, positive subjective norms, high perceived behavioral control, positive attitudes toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, low barriers to the vaccine, and scoring high on self-efficacy for getting the vaccine. Concerns about rushed vaccine development appear to reduce vaccine uptake intent, as well as willingness to get the vaccine under EUA.

Conclusions: COVID-19 vaccine-related messages should both address concerns about the vaccine and its development and reinforce benefits of the vaccine (both factors significant in both models). Vaccine efforts may need to go beyond just communications campaigns correcting misinformation about a COVID-19 vaccine to also focus on re-establishing public trust in government agencies.

Keywords: Health Belief Model; Theory of planned behavior.

PubMed Disclaimer

References

    1. World Health Organization . 2020. Coronavirus Disease (COVID-19)https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available at:
    1. Bults M, Beaujean DJ, Richardus JH, Voeten HA. Perceptions and behavioral responses of the general public during the 2009 influenza A (H1N1) pandemic: a systematic review. Disast Med Public Health Preparedness. 2015;9:207–219. - PubMed
    1. Bostock B. 2020. Fauci Said it Will Take 12 to 18 Months to Get a Coronavirus Vaccine in the US. Experts Say a Quick Approval Could Be Risky.https://www.businessinsider.com/coronavirus-vaccine-quest-18-months-fauc... Available at:
    1. Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;1:305–306. - PubMed
    1. Soucheray S. 2020. Phase 3 Trial for Moderna COVID-19 Vaccine Begins Amid US Summer Surge.https://www.cidrap.umn.edu/news-perspective/2020/07/phase-3-trial-modern... Available at:

Substances